Less Drowsy Motion Sickness Relief Tablet
NDC Package 11822-0775-3
Package Information
Less Drowsy Motion Sickness Relief (meclizine hcl) tablets is meclizine is an antihistamine that is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. This formulation utilizes a tablet delivery system. Marketed by Rite Aid Corporation, this product is identified by NDC 11822-0775 and is authorized under FDA application M009.
Identification & Billing
- RxCUI: 995666 - meclizine HCl 25 MG Oral Tablet
- RxCUI: 995666 - meclizine hydrochloride 25 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11822 - Rite Aid Corporation
- 11822-0775 - Less Drowsy Motion Sickness Relief
- 11822-0775-3 - 10 TABLET in 1 VIAL, PLASTIC
- 11822-0775 - Less Drowsy Motion Sickness Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11822-0775). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11822-0775-3 identifies a specific commercial package of 10 tablet in 1 vial, plastic of Less Drowsy Motion Sickness Relief, a human over the counter drug labeled by Rite Aid Corporation. This tablet is formulated for oral use and contains meclizine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rite Aid Corporation on June 30, 2019. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Meclizine is an antihistamine that is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It may also be used to reduce dizziness and loss of balance (vertigo) caused by inner ear problems.
How is this Rite Aid Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11822077503. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.